2016 Federal Advocacy Priorities
Each year, Komen works to identify, through a transparent and broad-based, intensive vetting and selection process, the policy issues that have the greatest potential impact on Komen’s mission. This process includes the collection of feedback from Komen Headquarters leadership, policy staff, and subject matter experts; Komen Affiliates from across the country; advisory groups including the Komen Advocacy Advisory Taskforce (KAAT), Advocates in Science (AIS), and Komen Scholars; and other stakeholders with a vested interest in breast cancer-related issues. The selected issues are the basis for Komen’s state and federal advocacy work in the coming year. Below are the 2016 Federal Advocacy Priorities for Susan G. Komen:
- Support for expanded federal funding for biomedical research, especially breast cancer researchat the National Institutes of Health (NIH) and the Department of Defense (DOD);
- Support state and federal funding for the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program(NBCCEDP);
- Advocate for policies to improve insurance coveragefor breast cancer treatments and screening, specifically pertaining to increased access to drug therapies and limiting out-of-pocket costs for diagnostic mammography; and
- Evaluate state and federal policies to increase awareness, education and access to clinical trialsfor all patient populations.
2016 California Advocacy Priorities
The Komen California Collaborative Public Policy Committee is in the early planning stages for 2016 Legislative plans, and have met with Assembly Speaker Toni Atkins’ office and presented bill ideas. Background information and language have been provided to Legislative Counsel. Below are the bill ideas that have been presented to Speaker Atkins:
- Extend Every Woman Counts coverage to include symptomatic women under 40. Currently, Komen San Diego provides this funding to Council of Community Clinics.
- Close the loophole in the Breast and Cervical Cancer Treatment Program (BCCTP) to cover women with a recurrence or re-diagnosis of breast cancer (recurrence or re-diagnosis of breast cancer is currently not covered through the BCCTPfor undocumented women).
- Cover Diagnostic mammograms up to parity with screening mammograms.